MDT

SEC source: 0001127602-20-013435 · form4.xml · nonDerivative · entry 1

OLEARY DENISE M · CIK 0001145159 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,544

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: This balance increased by 495 shares due to exempt transactions such as dividend reinvestment.

SEC source: 0001127602-20-007086 · form4.xml · nonDerivative · entry 1

ISHRAK OMAR · CIK 0001523102 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 605,190

F1 · price: The price in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $113.65 to $113.70, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in the footnote to this Form 4.

F2 · balance_after: This balance increased by 1,994 shares due to exempt transactions such as dividend reinvestment.

SEC source: 0001127602-19-035863 · form4.xml · derivative · entry 11

Kuntz Richard · CIK 0001341125 · SVP & Chief Medical & Science

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 38,558 shares

Expires 2023-07-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: This option to purchase 38,558 New Medtronic ordinary shares for $55.32 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 38,558 Medtronic common stock shares for $55.32 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.

SEC source: 0001127602-19-035863 · form4.xml · derivative · entry 10

Kuntz Richard · CIK 0001341125 · SVP & Chief Medical & Science

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 1,808 shares

Expires 2023-07-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: This option to purchase 1,808 New Medtronic ordinary shares for $55.32 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 1,808 Medtronic common stock shares for $55.32 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.

SEC source: 0001127602-19-035863 · form4.xml · derivative · entry 9

Kuntz Richard · CIK 0001341125 · SVP & Chief Medical & Science

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 2,404 shares

Expires 2022-10-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: This option to purchase 2,404 New Medtronic ordinary shares for $41.60 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 2,404 Medtronic common stock shares for $41.60 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.

SEC source: 0001127602-19-035863 · form4.xml · nonDerivative · entry 8

Kuntz Richard · CIK 0001341125 · SVP & Chief Medical & Science

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,013

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $113.48 to $113.66, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes to this Form 4.

F1 · balance_after: This balance increased by 283 shares due to exempt transactions such as dividend reinvestment.

SEC source: 0001127602-19-035863 · form4.xml · nonDerivative · entry 7

Kuntz Richard · CIK 0001341125 · SVP & Chief Medical & Science

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 109,571

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: This balance increased by 283 shares due to exempt transactions such as dividend reinvestment.

SEC source: 0001127602-19-035863 · form4.xml · nonDerivative · entry 6

Kuntz Richard · CIK 0001341125 · SVP & Chief Medical & Science

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,013

F1 · balance_after: This balance increased by 283 shares due to exempt transactions such as dividend reinvestment.

SEC source: 0001127602-19-035863 · form4.xml · nonDerivative · entry 5

Kuntz Richard · CIK 0001341125 · SVP & Chief Medical & Science

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,821

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: This balance increased by 283 shares due to exempt transactions such as dividend reinvestment.

SEC source: 0001127602-19-035863 · form4.xml · nonDerivative · entry 4

Kuntz Richard · CIK 0001341125 · SVP & Chief Medical & Science

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,013

F1 · balance_after: This balance increased by 283 shares due to exempt transactions such as dividend reinvestment.

SEC source: 0001127602-19-035863 · form4.xml · nonDerivative · entry 3

Kuntz Richard · CIK 0001341125 · SVP & Chief Medical & Science

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,417

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: This balance increased by 283 shares due to exempt transactions such as dividend reinvestment.

SEC source: 0001127602-19-035863 · form4.xml · nonDerivative · entry 2

Kuntz Richard · CIK 0001341125 · SVP & Chief Medical & Science

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,013

F1 · balance_after: This balance increased by 283 shares due to exempt transactions such as dividend reinvestment.

SEC source: 0001127602-19-035863 · form4.xml · nonDerivative · entry 1

Kuntz Richard · CIK 0001341125 · SVP & Chief Medical & Science

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,032

F1 · balance_after: This balance increased by 283 shares due to exempt transactions such as dividend reinvestment.

SEC source: 0001127602-19-035546 · form4.xml · nonDerivative · entry 1

Lerman Bradley E · CIK 0001559405 · SVP General Counsel & Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,802

F1 · balance_after: This balance increased by 171 shares due to exempt transactions such as dividend reinvestment.

SEC source: 0001127602-19-034597 · form4.xml · nonDerivative · entry 1

ANDERSON RICHARD H · CIK 0001200334 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 95,231

F1 · price: The price reported is the weighted average price. Shares were purchased in multiple transactions at prices ranging from $113.285 to $113.290. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a securityholder of the Issuer, full information regarding the number of shares purchased at each price.

F2 · balance_after: This balance increased by 319 shares due to exempt transactions such as dividend reinvestment.

SEC source: 0001127602-19-034887 · form4.xml · nonDerivative · entry 2

ISHRAK OMAR · CIK 0001523102 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · 2019 GRAT

Disclosed balance after: 18,182

SEC source: 0001127602-19-034887 · form4.xml · nonDerivative · entry 1

ISHRAK OMAR · CIK 0001523102 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 594,425

F1 · balance_after: This balance increased by 2,184 shares due to exempt transactions such as dividend reinvestment.

F2 · balance_after: Includes 7,615 shares previously reported as owned indirectly through the 2017 GRAT.

SEC source: 0001127602-19-034132 · form4.xml · derivative · entry 8

WHITE ROBERT JOHN · CIK 0001726709 · EVP & President MITG

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 26,724 shares

Expires 2025-01-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

SEC source: 0001127602-19-034132 · form4.xml · derivative · entry 7

WHITE ROBERT JOHN · CIK 0001726709 · EVP & President MITG

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 25,442 shares

Expires 2023-12-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

SEC source: 0001127602-19-034132 · form4.xml · nonDerivative · entry 6

WHITE ROBERT JOHN · CIK 0001726709 · EVP & President MITG

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,068

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.76 to $111.54, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc or the staff of the Securities and Exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001127602-19-034132 · form4.xml · nonDerivative · entry 5

WHITE ROBERT JOHN · CIK 0001726709 · EVP & President MITG

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,651

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.73 to $110.72, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc or the staff of the Securities and Exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001127602-19-034132 · form4.xml · nonDerivative · entry 4

WHITE ROBERT JOHN · CIK 0001726709 · EVP & President MITG

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,510

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.73 to $111.51, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc or the staff of the Securities and Exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001127602-19-034132 · form4.xml · nonDerivative · entry 3

WHITE ROBERT JOHN · CIK 0001726709 · EVP & President MITG

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,750

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.72 to $110.70, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc or the staff of the Securities and Exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001127602-19-034132 · form4.xml · nonDerivative · entry 2

WHITE ROBERT JOHN · CIK 0001726709 · EVP & President MITG

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 104,234

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

SEC source: 0001127602-19-034132 · form4.xml · nonDerivative · entry 1

WHITE ROBERT JOHN · CIK 0001726709 · EVP & President MITG

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,510

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

SEC source: 0001127602-19-033063 · form4.xml · derivative · entry 7

COYLE MICHAEL J · CIK 0001233311 · EVP & Group Pres, Cardiac&Vasc

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 36,874 shares

Expires 2022-07-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F5 · derivative.exercise_date: This option to purchase 75,548 New Medtronic ordinary shares for $38.81 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 75,548 Medtronic common stock shares for $38.81 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.

SEC source: 0001127602-19-033063 · form4.xml · nonDerivative · entry 4

COYLE MICHAEL J · CIK 0001233311 · EVP & Group Pres, Cardiac&Vasc

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 188,262

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $111.98 to $112.15, inclusive. The reporting person undertakes to provide to Medtronic plc , any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes to this Form 4.

SEC source: 0001127602-19-033063 · form4.xml · nonDerivative · entry 3

COYLE MICHAEL J · CIK 0001233311 · EVP & Group Pres, Cardiac&Vasc

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 192,059

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $110.96 to $111.88, inclusive. The reporting person undertakes to provide to Medtronic plc , any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes to this Form 4.

SEC source: 0001127602-19-033063 · form4.xml · nonDerivative · entry 2

COYLE MICHAEL J · CIK 0001233311 · EVP & Group Pres, Cardiac&Vasc

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 217,769

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $109.96 to $110.96, inclusive. The reporting person undertakes to provide to Medtronic plc , any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes to this Form 4.

SEC source: 0001127602-19-033063 · form4.xml · nonDerivative · entry 1

COYLE MICHAEL J · CIK 0001233311 · EVP & Group Pres, Cardiac&Vasc

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 225,136

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

SEC source: 0001127602-19-032879 · form4.xml · derivative · entry 8

COYLE MICHAEL J · CIK 0001233311 · EVP & Group Pres, Cardiac&Vasc

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 1,202 shares

Expires 2022-10-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F4 · derivative.exercise_date: This option to purchase 2,404 New Medtronic ordinary shares for $41.60 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 2,404 Medtronic common stock shares for $41.60 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.

SEC source: 0001127602-19-032879 · form4.xml · derivative · entry 7

COYLE MICHAEL J · CIK 0001233311 · EVP & Group Pres, Cardiac&Vasc

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,874

Underlying: Ordinary Shares · 900 shares

Expires 2022-07-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F3 · derivative.exercise_date: This option to purchase 75,548 New Medtronic ordinary shares for $38.81 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 75,548 Medtronic common stock shares for $38.81 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.

SEC source: 0001127602-19-032879 · form4.xml · nonDerivative · entry 4

COYLE MICHAEL J · CIK 0001233311 · EVP & Group Pres, Cardiac&Vasc

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 188,262

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

SEC source: 0001127602-19-032879 · form4.xml · nonDerivative · entry 3

COYLE MICHAEL J · CIK 0001233311 · EVP & Group Pres, Cardiac&Vasc

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 189,464

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

SEC source: 0001127602-19-032879 · form4.xml · nonDerivative · entry 2

COYLE MICHAEL J · CIK 0001233311 · EVP & Group Pres, Cardiac&Vasc

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 188,262

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $109.50 to $109.61, inclusive. The reporting person undertakes to provide to Medtronic plc , any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes to this Form 4.

SEC source: 0001127602-19-032879 · form4.xml · nonDerivative · entry 1

COYLE MICHAEL J · CIK 0001233311 · EVP & Group Pres, Cardiac&Vasc

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 189,162

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

SEC source: 0001127602-19-031733 · form4.xml · derivative · entry 11

WHITE ROBERT JOHN · CIK 0001726709 · EVP & President MITG

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,442

Underlying: Ordinary Shares · 5,313 shares

Expires 2023-12-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

SEC source: 0001127602-19-031733 · form4.xml · derivative · entry 10

WHITE ROBERT JOHN · CIK 0001726709 · EVP & President MITG

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 37,209 shares

Expires 2022-12-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

SEC source: 0001127602-19-031733 · form4.xml · derivative · entry 9

WHITE ROBERT JOHN · CIK 0001726709 · EVP & President MITG

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 9,643 shares

Expires 2021-11-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

SEC source: 0001127602-19-031733 · form4.xml · nonDerivative · entry 8

WHITE ROBERT JOHN · CIK 0001726709 · EVP & President MITG

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,068

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F7 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.46 to $110.01, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc or the staff of the Securities and Exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001127602-19-031733 · form4.xml · nonDerivative · entry 7

WHITE ROBERT JOHN · CIK 0001726709 · EVP & President MITG

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,032

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F6 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.46 to $109.43, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc or the staff of the Securities and Exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001127602-19-031733 · form4.xml · nonDerivative · entry 6

WHITE ROBERT JOHN · CIK 0001726709 · EVP & President MITG

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,381

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

SEC source: 0001127602-19-031733 · form4.xml · nonDerivative · entry 5

WHITE ROBERT JOHN · CIK 0001726709 · EVP & President MITG

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,068

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.45 to $110.18, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc or the staff of the Securities and Exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001127602-19-031733 · form4.xml · nonDerivative · entry 4

WHITE ROBERT JOHN · CIK 0001726709 · EVP & President MITG

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,730

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.44 to $109.44, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc or the staff of the Securities and Exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001127602-19-031733 · form4.xml · nonDerivative · entry 3

WHITE ROBERT JOHN · CIK 0001726709 · EVP & President MITG

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 95,158

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

SEC source: 0001127602-19-031733 · form4.xml · nonDerivative · entry 2

WHITE ROBERT JOHN · CIK 0001726709 · EVP & President MITG

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,949

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.46 to $109.98, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc or the staff of the Securities and Exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001127602-19-031733 · form4.xml · nonDerivative · entry 1

WHITE ROBERT JOHN · CIK 0001726709 · EVP & President MITG

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,711

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2 · balance_after: This balance increased by 151 shares due to exempt transactions such as dividend reinvestment.

SEC source: 0001127602-19-031732 · form4.xml · derivative · entry 8

COYLE MICHAEL J · CIK 0001233311 · EVP & Group Pres, Cardiac&Vasc

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,202

Underlying: Ordinary Shares · 1,202 shares

Expires 2022-10-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F4 · derivative.exercise_date: This option to purchase 2,404 New Medtronic ordinary shares for $41.60 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 2,404 Medtronic common stock shares for $41.60 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.

SEC source: 0001127602-19-031732 · form4.xml · derivative · entry 7

COYLE MICHAEL J · CIK 0001233311 · EVP & Group Pres, Cardiac&Vasc

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,774

Underlying: Ordinary Shares · 37,774 shares

Expires 2022-07-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F3 · derivative.exercise_date: This option to purchase 75,548 New Medtronic ordinary shares for $38.81 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 75,548 Medtronic common stock shares for $38.81 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.

SEC source: 0001127602-19-031732 · form4.xml · nonDerivative · entry 4

COYLE MICHAEL J · CIK 0001233311 · EVP & Group Pres, Cardiac&Vasc

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 188,262

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.